tiprankstipranks
BeiGene’s Financial and Market Challenges: Navigating Risks in Drug Acceptance, Competition, and Geopolitical Tensions
PremiumCompany AnnouncementsBeiGene’s Financial and Market Challenges: Navigating Risks in Drug Acceptance, Competition, and Geopolitical Tensions
10d ago
BeiGene reports Q3 EPS ($1.15), consensus ($1.20)
Premium
The Fly
BeiGene reports Q3 EPS ($1.15), consensus ($1.20)
11d ago
BeiGene, Ltd. (BGNE) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
BeiGene, Ltd. (BGNE) Q3 Earnings Cheat Sheet
13d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
BeiGene says FDA’s ODAC sees favorable benefit-risk profile of PD-1 inhibitors
Premium
The Fly
BeiGene says FDA’s ODAC sees favorable benefit-risk profile of PD-1 inhibitors
2M ago
BeiGene initiated with an Outperform at JMP Securities
Premium
The Fly
BeiGene initiated with an Outperform at JMP Securities
2M ago
BeiGene price target raised to $198 from $181.50 at BofA
PremiumThe FlyBeiGene price target raised to $198 from $181.50 at BofA
3M ago
BeiGene price target raised to $288 from $269 at Citi
Premium
The Fly
BeiGene price target raised to $288 from $269 at Citi
4M ago
BeiGene reports Q2 GAAP EPS (9c), consensus ($2.15)
Premium
The Fly
BeiGene reports Q2 GAAP EPS (9c), consensus ($2.15)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100